Bot Yakubu Sunday

Bot Yakubu Sunday

Auto-generated profile, based on publicly available information

Bot Yakubu Sunday

Kampala International University, Western Campus

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2025 in F1000Research
Verified
Journal Article
Open access
SDSwase Dominic
Swase Dominic
RMRegan Mujinya
Regan Mujinya
KKKeith L Kayanja
Keith L Kayanja
BSBot Yakubu Sunday
Bot Yakubu Sunday
RDReuben Samson Dangana
Reuben Samson Dangana
JKJoseph Kibirige
Joseph Kibirige
Background Network pharmacology and molecular docking have emerged as important in modern herbal drug discovery, offering systems-level understanding into phytochemical interactions and therapeutic mechanisms. This review aimed to evaluate the application of integrated network pharmacology and molecular docking in herbal medicine research Methods A systematic search was conducted across PubMed, Scopus, and Web of Science for studies published between 2010 and August, 2025. Eligible studies included both network pharmacology and molecular docking in medicinal plants, botanical formulations, or isolated phytochemicals. Screening and selection followed PRISMA-ScR guidelines. Data were extracted on study characteristics, computational platforms, biological validation strategies, phytochemical profiles, protein targets, and mechanistic pathways. Results 36 studies met the eligibility criteria. Publications increased significantly after 2020, with most originating from Asia, particularly China (55.6%) and India (25.0%). Majority (61.1%) employed purely in silico pipelines, while 22.2% combined computational and in vitro validation, and 16.7% incorporated in vivo models. Flavonoids such as quercetin, kaempferol, apigenin, and luteolin accounted for most docked phytochemicals. Key molecular targets included ESR1, EGFR, AKT1, TNF, CASP3, and PTGS2, aligning predominantly with cancer, inflammatory, and metabolic pathways. Key signaling cascades PI3K-Akt, MAPK/ERK, NF-κB, and Wnt/β-catenin were consistently reported. Almost half of the studies (47.2%) integrated molecular dynamics simulations, while ADMET screening was reported in 71.4% of cases. Conclusion This review demonstrates that integrated network pharmacology and molecular docking have become foundational in herbal medicine research and growing with advances in computational biology. These approaches reveal multi-target mechanisms supporting the therapeutic potential of phytochemicals, yet translational progress is constrained by inconsistent pipelines. Strengthening validation frameworks, broadening phytochemical discovery beyond common flavonoids, and enhancing global research participation will be essential to accelerate clinically relevant herbal drug development.

26 December 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
BSBot Yakubu Sunday
Bot Yakubu Sunday
SDSwase Dominic
Swase Dominic
IHIdania Hidalgo
Idania Hidalgo
UBUmi Omar Bunu
Umi Omar Bunu
CICharles Idehen
Charles Idehen
Alzheimer’s disease (AD) remains the most common cause of dementia worldwide and one of the greatest health challenges of the twenty-first century. Traditionally viewed as a neurodegenerative disorder defined by amyloid-β plaques and tau tangles, recent evidence implicates systemic metabolic dysfunction and endothelial injury as key drivers of the disease progression. Insulin resistance, dyslipidemia, and chronic hyperglycemia impair neuronal glucose utilization and insulin signaling, leading to mitochondrial dysfunction, oxidative stress, and tau hyperphosphorylation. Concurrently, abnormal lipid metabolism and the presence of the apolipoprotein E4 allele accelerate amyloidogenic processing, while advanced glycation end-products (AGEs) formed during hyperglycemia activate RAGE-mediated inflammatory pathways that amplify neuronal injury. Endothelial dysfunction further compounds these effects by reducing nitric oxide (NO) bioavailability, disrupting the blood–brain barrier, and diminishing cerebral perfusion inhibiting amyloid clearance and intensifying neuroinflammation. These interconnected metabolic and vascular abnormalities establish a “metabolic–vascular–neurodegenerative axis” that links systemic disease to progressive neuronal degeneration. Understanding this integrative framework shifts the perspective of AD from a purely brain-centered disorder to a systemic, multi-organ pathology. Emerging therapeutic strategies that combine metabolic regulation, endothelial protection, and anti-inflammatory approaches offer a more comprehensive path toward prevention and disease modification. future research and clinical interventions can achieve a sustained neuroprotection by addressing the metabolic and vascular roots of AD.

18 November 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
UBUmi Omar Bunu
Umi Omar Bunu
TATamale Andrew
Tamale Andrew
BSBot Yakubu Sunday
Bot Yakubu Sunday
MIMikail Umar Isyaku
Mikail Umar Isyaku
Background Youth substance abuse is an escalating public health challenge in Uganda, undermining individual well-being, family stability, and community development. Understanding the influence of family and community dynamics is critical for designing effective prevention strategies. Aim This study investigated the relationship between family and community factors and substance abuse among youths in Bushenyi District, Western Uganda. Methods A cross-sectional study design was employed. Structured questionnaires were administered to 381 youths aged 18–30 years, collecting sociodemographic information and data on family and community influences (parental drug use, home rules, peer influence, and law enforcement). Descriptive statistics summarised the data, chi-square tests assessed associations, and logistic regression identified predictors at a 5% significance level. Results Early initiation of drug use was common, particularly in bars and among peer groups. Substance abuse was significantly associated with parental drug use (χ 2 = 102.68, p < 0.001), living arrangements (χ 2 = 21.46, p = 0.001), peer influence (χ 2 = 13.40, p = 0.001), and weak law enforcement (χ 2 = 12.95, p = 0.001). Regression analysis showed that strict home rules were protective (Exp(B) = 0.325, p < 0.001), while weak law enforcement increased the risk of substance abuse (Exp(B) = 0.357, p = 0.003). Conclusion Family and community dynamics, particularly parental behaviour, peer pressure, and ineffective institutional regulation, are central drivers of youth substance abuse. Strengthening parental involvement, enforcing household rules, and improving law enforcement and community-based interventions are important in reducing the burden of substance use. The study highlights the need for multisectoral action involving families, schools, religious institutions, and law enforcement, while providing evidence to inform prevention strategies and future research on contextual risk pathways.

1 January 2026 in Anemia
Verified
Journal Article
Open access
BSBot Yakubu Sunday
Bot Yakubu Sunday
SDSwase Dominic
Swase Dominic
MOMichael Okon
Michael Okon
SBSarad Pawar Naik Bukke
Sarad Pawar Naik Bukke
ICIdehen Iyore Charles
Idehen Iyore Charles
EDEze Daniel
Eze Daniel
Background: Sickle cell anaemia (SCA) is a hereditary haemoglobin disorder that continues to pose a significant public health burden worldwide. This systematic review aimed to synthesise evidence on plant‐derived therapies investigated for their antisickling, antioxidant and membrane‐stabilising effects in the management of SCA. Methods: A systematic search of PubMed, Scopus and Web of Science was performed according to PRISMA 2020 guidelines to identify studies (2010–2025) evaluating plant‐based interventions for SCA. Results: Thirty‐four studies published between 2010 and 2025 were included, with the majority (58.8%) published between 2018 and 2025, while 20.6% were published between 2010 and 2012. Most studies originated from Africa (58.8%), particularly Nigeria and the Democratic Republic of the Congo, followed by Asia (26.5%). Carica papaya was the most frequently investigated medicinal plant (21.2%), and leaves were the most commonly used plant part (39%). Strong antisickling activity was reported in 41.2% of studies, while 26.5% demonstrated inhibition of haemoglobin S (HbS) polymerisation and 17.6% reported membrane‐stabilising or antihaemolytic effects. Antioxidant activity accounted for 45.5% of all oxidative assessments. Overall, inhibition of HbS polymerisation was the most frequently reported mechanism of action, identified in 60.6% of the included studies. Conclusion: The evidence demonstrates that plant‐derived extracts and phytochemicals possess significant antisickling, antioxidant and membrane‐protective activity, supporting their potential as adjunct therapies for SCA. Nonetheless, standardisation of experimental protocols, toxicological evaluation and clinical trials are essential to advance towards clinical application.

17 April 2026 in Natural Product Communications
Verified
Journal Article
Open access
NKNsibambi Ronald Kizza
Nsibambi Ronald Kizza
SBSarad Pawar Naik Bukke
Sarad Pawar Naik Bukke
UYUngo-Kore Hussain Yahaya
Ungo-Kore Hussain Yahaya
BSBot Yakubu Sunday
Bot Yakubu Sunday
Diabetes mellitus affects millions of people around the globe. It occurs when the pancreas does not produce enough insulin or the cells in the body become resistant to the insulin produced. The result is elevated levels of glucose in the bloodstream (hyperglycemia). Untreated diabetes mellitus leads to serious complications such as cardiovascular disease, stroke, kidney failure, eye disease, neuropathy and amputation. Sustained-release drug delivery systems provide many benefits to patients, including: consistent therapeutic plasma levels, fewer doses per day, and increased compliance with medication regimens. Polymers derived from natural sources are becoming increasingly popular in sustained-release formulations because they have low toxicity, biocompatibility, and biodegradability, making them suitable for drug delivery. One example of a natural polymer is the mucilage (gum) from Hibiscus rosa-sinensis ( H . rosa-sinensis ). The mucilage has excellent swelling properties, can form a gel matrix, maintain its structural integrity and be compatible with synthetic drug delivery systems. The mucilage is easily extracted from the plant using environmentally friendly techniques, and results in a stable polymer that is hydrophilic and has a pH-tolerant capacity, making it suitable for developing controlled drug delivery systems. Drug delivery systems formed from H. rosa-sinensis will release drugs via diffusion and/or erosion, following zero-order or higuchi kinetics. Metformin was chosen as a model drug; however, the polymer has broader application potential. Studies are needed to establish standardization, develop microbial stability, and validate clinical efficacy through additional systematic studies.

15 June 2026 in F1000Research
Verified
Journal Article
Open access
PDF file
BSBot Yakubu Sunday
Bot Yakubu Sunday
SDSwase Dominic
Swase Dominic
IHIdania Hidalgo
Idania Hidalgo
UBUmi Omar Bunu
Umi Omar Bunu
CICharles Idehen
Charles Idehen
Alzheimer’s disease (AD) remains the most common cause of dementia worldwide and one of the greatest health challenges of the twenty-first century. Traditionally viewed as a neurodegenerative disorder defined by amyloid-β plaques and tau tangles, recent evidence implicates systemic metabolic dysfunction and endothelial injury as key drivers of the disease progression. Insulin resistance, dyslipidemia, and chronic hyperglycemia impair neuronal glucose utilization and insulin signaling, leading to mitochondrial dysfunction, oxidative stress, and tau hyperphosphorylation. Concurrently, abnormal lipid metabolism and the presence of the apolipoprotein E4 allele accelerate amyloidogenic processing, while advanced glycation end-products (AGEs) formed during hyperglycemia activate RAGE-mediated inflammatory pathways that amplify neuronal injury. Endothelial dysfunction further compounds these effects by reducing nitric oxide (NO) bioavailability, disrupting the blood–brain barrier, and diminishing cerebral perfusion inhibiting amyloid clearance and intensifying neuroinflammation. These interconnected metabolic and vascular abnormalities establish a “metabolic–vascular–neurodegenerative axis” that links systemic disease to progressive neuronal degeneration. Understanding this integrative framework shifts the perspective of AD from a purely brain-centered disorder to a systemic, multi-organ pathology. Emerging therapeutic strategies that combine metabolic regulation, endothelial protection, and anti-inflammatory approaches offer a more comprehensive path toward prevention and disease modification. Future research and clinical interventions can achieve a sustained neuroprotection by addressing the metabolic and vascular roots of AD.